Twice- and Thrice-daily Cephalexin Dosing for Staphylococcus aureus Infections in Children

Amanda Gwee1,2,3, Julie Autmizguine4,5,6, Nigel Curtis1,2,3

  • 1From the Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Abstract

Insights

This study developed new dosing schedules for cephalexin in children to treat Staphylococcus aureus infections. Twice-daily and thrice-daily regimens were identified to improve treatment adherence and reduce medication burden.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Pediatric Infectious Diseases
  • Antibiotic Dosing Optimization

Background:

  • Cephalexin is a common antibiotic for methicillin-susceptible Staphylococcus aureus (MSSA) infections in children.
  • Standard dosing (4 times daily) is often reduced to improve patient adherence.
  • Population pharmacokinetics can inform optimized dosing strategies.

Purpose of the Study:

  • To develop a population pharmacokinetic model for cephalexin in pediatric patients.
  • To determine appropriate twice-daily (BID) and thrice-daily (TID) cephalexin dosing regimens for MSSA infections.
  • To achieve pharmacodynamic targets for effective treatment in children.

Main Methods:

  • Utilized a nonlinear mixed-effects modeling approach for population pharmacokinetics.
  • Data from a prospective pharmacokinetic study in 12 children (1-16 years) with bone and joint infections.
  • Simulations to identify BID and TID regimens ensuring ≥90% of children meet pharmacodynamic targets.

Main Results:

  • A one-compartment model with a transit compartment for oral absorption delay was established.
  • For BID dosing, required doses ranged from 22-45 mg/kg (MIC 1-2 mg/L) to 80 mg/kg (MIC 4 mg/L).
  • For TID dosing, required doses ranged from 15-25 mg/kg (MIC 1-2 mg/L) to 45 mg/kg (MIC 4 mg/L).

Conclusions:

  • Proposed BID and TID cephalexin dosing regimens for prospective evaluation.
  • Reduced dosing frequency can decrease the medication burden for pediatric patients.
  • Optimized dosing can enhance treatment compliance for MSSA infections in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
172
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
137
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
130
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
160
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
152